← brief for 2026-08-10 · Slowing decline

Calcineurin inhibitor versus mycophenolate mofetil along with rituximab in non-genetic calcineurin inhibitor resistant steroid resistant nephrotic syndrome: retrospective observation from western India

Key takeaways

This look-back study from western India compared two drug combinations (a calcineurin inhibitor versus mycophenolate, both with rituximab) in children with hard-to-treat nephrotic syndrome. It is observational, so it suggests, but does not prove, which works better.

Who did this work

Disha Kalpit Bhatt (Institute of Transplantation Sciences) · Shahenaz Kapadia (Institute of Transplantation Sciences) · Anshuman Saha (Institute of Transplantation Sciences) · Kinnari Vala (Institute of Transplantation Sciences)

Source

Indexed paper · OpenAlex — CKD concept sweep (DB seed + weekly delta) · 2026-08-04
https://doi.org/10.21203/rs.3.rs-10511566/v1